Novel platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases: synthesis, crystal structure and cytotoxic activities - PubMed

Affiliations

• PMID: 20871881
• DOI: 10.1039/c0dt00572j

Novel platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases: synthesis, crystal structure and cytotoxic activities

Amanda P Neves et al. Dalton Trans. 2010.

Abstract

The first examples of platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases have been synthesised and their crystal structures are described. Neutral and charged complexes have been obtained, fully characterised and their cytotoxic activities have also been investigated. 3-[(R(1)-amino)(pyridin-2-yl)methyl]-2-hydroxy-1,4-naphthoquinones (R(1) = n-Bu, HL1; Bn, HL2; furfuryl, HL3; n-heptyl, HL4 and n-decyl, HL5) coordinate to platinum(II) through the two nitrogen atoms. The neutral complexes cis-[Pt(HL)Cl(2)] 1a-5a are analogous to cisplatin with the bidentate ligand HL and two chlorine atoms occupying cis positions. In the charged complexes cis-[Pt(L(-))(NH(3))(2)]NO(3)1b-5b the deprotonated form of the ligand L(-) also coordinates via the nitrogen atoms, and the other two positions around the platinum(II) ion are completed with NH(3) ligands. The cytotoxic activities of all compounds have been tested for six different cancer cell lines: MDA-MB-435 (melanoma), HL-60 (promyelocytic leukaemia), HCT-8 (colon), SF-295 (brain), OVCAR-8 (ovary) and PC-3 (prostate). Proligands HL4 and HL5 have exhibited high activity against HL-60 (IC(50) = 1.9 and 3.8 μmol L(-1), respectively), HCT-8 (IC(50) = 1.6 and 1.7 μmol L(-1), respectively) and SF-295 (IC(50) = 1.1 and 1.7 μmol L(-1), respectively). The chlorido complexes 1a-5a have shown high to moderate cytotoxic activities, complex 4a (R(1) = n-heptyl) being more active than proligand HL4 against melanoma (IC(50) = 6.4 and > 40 μmol L(-1), respectively) and more active than cisplatin against all tested cell lines. Among the amine charged complexes only 4b and 5b have exhibited significant cytotoxic activity against the tested cell lines, although they were only moderately active against the PC-3 cell line (IC(50) = 29.9 and 15.6 μmol L(-1), respectively). In general the compounds with the longest carbon chains (R(1) = n-heptyl and n-decyl) have exhibited the highest activities.

Similar articles

• Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.

  Primik MF, Göschl S, Jakupec MA, Roller A, Keppler BK, Arion VB. Primik MF, et al. Inorg Chem. 2010 Dec 6;49(23):11084-95. doi: 10.1021/ic101633z. Epub 2010 Oct 27. Inorg Chem. 2010. PMID: 20979395

• Exploring the DNA binding/cleavage, cellular accumulation and topoisomerase inhibition of 2-hydroxy-3-(aminomethyl)-1,4-naphthoquinone Mannich bases and their platinum(II) complexes.

  Neves AP, Pereira MX, Peterson EJ, Kipping R, Vargas MD, Silva FP Jr, Carneiro JW, Farrell NP. Neves AP, et al. J Inorg Biochem. 2013 Feb;119:54-64. doi: 10.1016/j.jinorgbio.2012.10.007. Epub 2012 Oct 15. J Inorg Biochem. 2013. PMID: 23186648

• Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.

  Vrzal R, Starha P, Dvorák Z, Trávnícek Z. Vrzal R, et al. J Inorg Biochem. 2010 Oct;104(10):1130-2. doi: 10.1016/j.jinorgbio.2010.07.002. Epub 2010 Jul 31. J Inorg Biochem. 2010. PMID: 20673688

• Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment.

  Che CM, Sun RW. Che CM, et al. Chem Commun (Camb). 2011 Sep 14;47(34):9554-60. doi: 10.1039/c1cc10860c. Epub 2011 Jun 14. Chem Commun (Camb). 2011. PMID: 21674082 Review.

• Development and current status of unconventional platinum anticancer complexes.

  Abu-Surrah AS. Abu-Surrah AS. Mini Rev Med Chem. 2007 Feb;7(2):203-11. doi: 10.2174/138955707779802615. Mini Rev Med Chem. 2007. PMID: 17305594 Review.

Cited by

• Synthesis and cytotoxic evaluation of a series of 2-amino-naphthoquinones against human cancer cells.

  de Moraes TA, Filha MJ, Camara CA, Silva TM, Soares BM, Bomfim IS, Pessoa C, Ximenes GC, Silva Junior VA. de Moraes TA, et al. Molecules. 2014 Aug 26;19(9):13188-99. doi: 10.3390/molecules190913188. Molecules. 2014. PMID: 25162959 Free PMC article.

• Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro.

  Ulukaya E, Ari F, Dimas K, Sarimahmut M, Guney E, Sakellaridis N, Yilmaz VT. Ulukaya E, et al. J Cancer Res Clin Oncol. 2011 Oct;137(10):1425-34. doi: 10.1007/s00432-011-1021-1. Epub 2011 Aug 2. J Cancer Res Clin Oncol. 2011. PMID: 21809029

• Investigations of Electronic, Structural, and In Silico Anticancer Potential of Persuasive Phytoestrogenic Isoflavene-Based Mannich Bases.

  Mutahir S, Khan MA, Mushtaq M, Deng H, Naglah AM, Almehizia AA, Al-Omar MA, Alrayes FI, Kalmouch A, El-Mowafi SA, Refat MS. Mutahir S, et al. Molecules. 2023 Aug 6;28(15):5911. doi: 10.3390/molecules28155911. Molecules. 2023. PMID: 37570881 Free PMC article.

• Mannich bases derived from lawsone and their metal complexes: synthetic strategies and biological properties.

  Olyaei A, Sadeghpour M, Khalaj M. Olyaei A, et al. RSC Adv. 2020 Aug 17;10(51):30265-30281. doi: 10.1039/d0ra05717g. eCollection 2020 Aug 17. RSC Adv. 2020. PMID: 35516010 Free PMC article. Review.

• Mannich bases in medicinal chemistry and drug design.

  Roman G. Roman G. Eur J Med Chem. 2015 Jan 7;89:743-816. doi: 10.1016/j.ejmech.2014.10.076. Epub 2014 Oct 30. Eur J Med Chem. 2015. PMID: 25462280 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Royal Society of Chemistry

• Miscellaneous

  • NCI CPTAC Assay Portal